Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Repair of iatrogenic ureteral injury secondary to breast cancer metastasis.

Levitske C, Gollapudi K, Pak S, Liang L.

Urol Case Rep. 2019 Sep 19;28:101024. doi: 10.1016/j.eucr.2019.101024. eCollection 2020 Jan.

2.

Positive surgical margins at radical prostatectomy in the United States: Institutional variations and predictive factors.

Pooli A, Salmasi A, Johnson DC, Lenis AT, Faiena I, Lebacle C, Golla V, Drakaki A, Gollapudi K, Blumberg J, Pantuck AJ, Chamie K.

Urol Oncol. 2019 Sep 16. pii: S1078-1439(19)30334-5. doi: 10.1016/j.urolonc.2019.08.016. [Epub ahead of print]

PMID:
31537483
3.

Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma and venous thrombus-Trends and effect on overall survival.

Lenis AT, Burton CS, Golla V, Pooli A, Faiena I, Johnson DC, Salmasi A, Drakaki A, Gollapudi K, Blumberg J, Pantuck AJ, Chamie K.

Urol Oncol. 2019 Sep;37(9):577.e9-577.e16. doi: 10.1016/j.urolonc.2019.03.009. Epub 2019 Mar 28.

PMID:
30930099
4.

Variation in surgical treatment patterns for patients with prostate cancer in the United States: Do patients in academic hospitals fare better?

Pooli A, Salmasi A, Faiena I, Lenis AT, Johnson DC, Lebacle C, Drakaki A, Gollapudi K, Blumberg J, Pantuck AJ, Chamie K.

Urol Oncol. 2019 Jan;37(1):63-70. doi: 10.1016/j.urolonc.2018.10.018. Epub 2018 Nov 13.

PMID:
30446452
5.

Treatment utilization and overall survival in patients receiving radical nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma: evaluation of updated treatment guidelines.

Upfill-Brown A, Lenis AT, Faiena I, Salmasi AH, Johnson DC, Pooli A, Drakaki A, Gollapudi K, Blumberg J, Pantuck AJ, Chamie K.

World J Urol. 2019 Jun;37(6):1157-1164. doi: 10.1007/s00345-018-2506-1. Epub 2018 Sep 28.

PMID:
30267197
6.

Association between renal mass biopsy and upstaging to perinephric fat involvement in a contemporary cohort of patients with clinical T1a renal cell carcinoma.

Salmasi A, Faiena I, Lenis AT, Pooli A, Johnson DC, Drakaki A, Gollapudi K, Blumberg J, Pantuck AJ, Chamie K.

Urol Oncol. 2018 Dec;36(12):527.e13-527.e19. doi: 10.1016/j.urolonc.2018.08.009. Epub 2018 Sep 15.

PMID:
30228094
7.

Overall survival in patients with residual disease after radical cystectomy and neoadjuvant chemotherapy.

Faiena I, Salmasi A, Mendhiratta N, Lenis AT, Pooli A, Drakaki A, Gollapudi K, Blumberg J, Pantuck AJ, Chamie K.

World J Urol. 2018 Nov;36(11):1825-1833. doi: 10.1007/s00345-018-2327-2. Epub 2018 May 11.

PMID:
29752514
8.

Phase II prospective randomized trial of weight loss prior to radical prostatectomy.

Henning SM, Galet C, Gollapudi K, Byrd JB, Liang P, Li Z, Grogan T, Elashoff D, Magyar CE, Said J, Cohen P, Aronson WJ.

Prostate Cancer Prostatic Dis. 2018 Jun;21(2):212-220. doi: 10.1038/s41391-017-0001-1. Epub 2017 Dec 4.

9.

Trends in usage of cytoreductive partial nephrectomy and effect on overall survival in patients with metastatic renal cell carcinoma.

Lenis AT, Salmasi AH, Donin NM, Faiena I, Johnson DC, Drakaki A, Gollapudi K, Blumberg J, Belldegrun AS, Pantuck AJ, Chamie K.

Urol Oncol. 2018 Feb;36(2):78.e21-78.e28. doi: 10.1016/j.urolonc.2017.09.030. Epub 2017 Nov 8.

PMID:
29128421
10.

Role of surgical approach on lymph node dissection yield and survival in patients with upper tract urothelial carcinoma.

Lenis AT, Donin NM, Faiena I, Salmasi A, Johnson DC, Drakaki A, Gollapudi K, Blumberg J, Belldegrun A, Pantuck A, Chamie K.

Urol Oncol. 2018 Jan;36(1):9.e1-9.e9. doi: 10.1016/j.urolonc.2017.09.001. Epub 2017 Oct 20.

PMID:
29066013
11.

Association between tumor-associated macrophage infiltration, high grade prostate cancer, and biochemical recurrence after radical prostatectomy.

Gollapudi K, Galet C, Grogan T, Zhang H, Said JW, Huang J, Elashoff D, Freedland SJ, Rettig M, Aronson WJ.

Am J Cancer Res. 2013 Nov 1;3(5):523-9. eCollection 2013.

12.

Effect of a low-fat fish oil diet on proinflammatory eicosanoids and cell-cycle progression score in men undergoing radical prostatectomy.

Galet C, Gollapudi K, Stepanian S, Byrd JB, Henning SM, Grogan T, Elashoff D, Heber D, Said J, Cohen P, Aronson WJ.

Cancer Prev Res (Phila). 2014 Jan;7(1):97-104. doi: 10.1158/1940-6207.CAPR-13-0261. Epub 2013 Oct 29.

13.

Correlates of bother following treatment for clinically localized prostate cancer.

Gore JL, Gollapudi K, Bergman J, Kwan L, Krupski TL, Litwin MS.

J Urol. 2010 Oct;184(4):1309-15. doi: 10.1016/j.juro.2010.06.012. Epub 2010 Aug 17.

PMID:
20723914
14.

Human palatine tonsil: a new potential tissue source of multipotent mesenchymal progenitor cells.

Janjanin S, Djouad F, Shanti RM, Baksh D, Gollapudi K, Prgomet D, Rackwitz L, Joshi AS, Tuan RS.

Arthritis Res Ther. 2008;10(4):R83. doi: 10.1186/ar2459. Epub 2008 Jul 28.

15.

Body mass index in ambulatory cerebral palsy patients.

Feeley BT, Gollapudi K, Otsuka NY.

J Pediatr Orthop B. 2007 May;16(3):165-9.

PMID:
17414774
16.

Advanced skeletal maturity in ambulatory cerebral palsy patients.

Gollapudi K, Feeley BT, Otsuka NY.

J Pediatr Orthop. 2007 Apr-May;27(3):295-8.

PMID:
17414012

Supplemental Content

Loading ...
Support Center